Bandara Aloka B, DeShazer David, Inzana Thomas J, Sriranganathan Nammalwar, Schurig Gerhardt G, Boyle Stephen M
Center for Molecular Medicine and Infectious Diseases, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061-0342, USA.
Microb Pathog. 2008 Sep;45(3):207-16. doi: 10.1016/j.micpath.2008.05.005. Epub 2008 Jun 3.
Burkholderia mallei is the etiologic agent of glanders in solipeds (horses, mules and donkeys), and incidentally in carnivores and humans. Little is known about the molecular mechanisms of B. mallei pathogenesis. The putative carboxy-terminal processing protease (CtpA) of B. mallei is a member of a novel family of endoproteases involved in the maturation of proteins destined for the cell envelope. All species and isolates of Burkholderia carry a highly conserved copy of ctpA. We studied the involvement of CtpA on growth, cell morphology, persistence, and pathogenicity of B. mallei. A sucrose-resistant strain of B. mallei was constructed by deleting a major portion of the sacB gene of the wild type strain ATCC 23344 by gene replacement, and designated as strain 23344DeltasacB. A portion of the ctpA gene (encoding CtpA) of strain 23344DeltasacB was deleted by gene replacement to generate strain 23344DeltasacBDeltactpA. In contrast to the wild type ATCC 23344 or the sacB mutant 23344DeltasacB, the ctpA mutant 23344DeltasacBDeltactpA displayed altered cell morphologies with partially or fully disintegrated cell envelopes. Furthermore, relative to the wild type, the ctpA mutant displayed slower growth in vitro and less ability to survive in J774.2 murine macrophages. The expression of mRNA of adtA, the gene downstream of ctpA was similar among the three strains suggesting that disruption of ctpA did not induce any polar effects. As with the wild type or the sacB mutant, the ctpA mutant exhibited a dose-dependent lethality when inoculated intraperitoneally into CD1 mice. The CD1 mice inoculated with a non-lethal dose of the ctpA mutant produced specific serum immunoglobulins IgG1 and IgG2a and were partially protected against challenge with wild type B. mallei ATCC 23344. These findings suggest that CtpA regulates in vitro growth, cell morphology and intracellular survival of B. mallei, and a ctpA mutant protects CD1 mice against glanders.
鼻疽伯克霍尔德菌是单蹄动物(马、骡和驴)鼻疽的病原体,偶尔也会感染食肉动物和人类。关于鼻疽伯克霍尔德菌致病的分子机制,人们了解甚少。鼻疽伯克霍尔德菌假定的羧基末端加工蛋白酶(CtpA)是一个新型内切蛋白酶家族的成员,该家族参与定位于细胞膜的蛋白质的成熟过程。伯克霍尔德菌的所有物种和菌株都携带一个高度保守的ctpA拷贝。我们研究了CtpA在鼻疽伯克霍尔德菌生长、细胞形态、存活及致病性方面所起的作用。通过基因置换缺失野生型菌株ATCC 23344的大部分sacB基因,构建了一株耐蔗糖的鼻疽伯克霍尔德菌菌株,命名为23344DeltasacB菌株。通过基因置换缺失23344DeltasacB菌株的部分ctpA基因(编码CtpA),以产生23344DeltasacBDeltactpA菌株。与野生型ATCC 23344或sacB突变体23344DeltasacB相比,ctpA突变体23344DeltasacBDeltactpA呈现出细胞形态改变,细胞膜部分或完全解体。此外,相对于野生型,ctpA突变体在体外生长较慢,在J774.2小鼠巨噬细胞中的存活能力较低。ctpA下游基因adtA的mRNA表达在这三种菌株中相似,这表明ctpA的破坏未诱导任何极性效应。与野生型或sacB突变体一样,ctpA突变体经腹腔接种到CD1小鼠中时表现出剂量依赖性致死率。接种非致死剂量ctpA突变体的CD1小鼠产生了特异性血清免疫球蛋白IgG1和IgG2a,并对野生型鼻疽伯克霍尔德菌ATCC 23344的攻击有部分保护作用。这些发现表明,CtpA调节鼻疽伯克霍尔德菌的体外生长、细胞形态和细胞内存活,且ctpA突变体可保护CD1小鼠免受鼻疽感染。